NSCLC 热消融的目标
Patient Selection Criteria
|
Patient Characteristics |
ACOSOG – z4033
|
High Risk
Limited Recurrence
Cyto-reduction Local Control Refractory Patient Refusal |
Major criteria (1) |
FEV1 ≤ 50%
DLCO ≤ 50%
|
|
Minor criteria (2)
|
|
FEV1 51-60%
DLCO 51-60%
Age ≥ 75 years
Pulmonary hypertension
Left ventricular function (EF ≤ 40%)
Resting or exercise arterial pO2 < 55 mmHg
pCO2 > 45 mmHg
|
|
基本概念 Key concept
理由之一:年龄大的患者治愈性手术切除不获益
Similar Long-term Survival of Elderly Patients w/ NSCLC Treated with Lobectomy or Wedge Resection within the SEER DatabaseAge-groups | No resection rate |
All | 15.7% |
< 65 years | 7.7% |
65-74 years | 14.1% |
> 75 years | 30.4% |
理由之二:早期或不可切除肺癌,仅仅观察处理预后差
治疗方式(例数) | 中位生存期(M) |
Surgery (43) | 46.2 |
Radiation (36) | 19.2 |
No treatment (49) | 14.2 |
cancer in 53% patients (compared to 43% after radiation)
理由之三:不可切除早期NSCLC病人的结果和特征
根据以上三个理由:选择热消融
1. >70岁,可治愈性外科切除的,(可切除的I/II期)-
2. 不可切除的早期(I/II期)肿瘤,(包括年轻患者,需要和放疗对比吗?)
3. 不可切除肿瘤(应该有大小之分,大的不可切除的肺癌,需要射频局部控制吗?)
1. 定义治疗包括
- Stages I or II with clinical comorbidities
- Stages I or II when the patient refuses Surgery
- Limited number of metastases
Definitive Therapy:NSCLC
2. Complementary to Other Therapies
化疗后残余癌,射频消融(Olympus)
3. 姑息治疗
Belfiore G, et al. AJR Am J Roentgenol 2004;183(4):1003-1.
Simon CJ, et al. Radiology 2007;243(1):268-75.
Palliation for Hemoptysis | RFA 1 |
NSCLC | RFA2 |
一个月后 | 咯血停止 |
Palliation for Pain Reduction | NSCLC |
姑息治疗:Treating Pulmonary Metastases:三种场景,低外科手术风险;高外科手术风险;复发性肺转移
除了 1. Definitive Therapy;2. Complementary to Other Therapies;3. Palliation
经皮消融还需要影像学的标准
1)Size
尽管多针射频,公认不可能实现完全消融的>3.5cm的病变
Fernando HC, et al. Ann Thorac Surg 2008;85(2):S780-4.
Carrafiello G, et al. Int J Surg 2008;6:65-9.
Vogl TJ, et al. Eur J Radiol 2011;77(2):346-57.
Herrera LJ, et al. J Thorac Cardiovasc Surg 2003;125(4):929-37.
Roy AM. Curr Probl Diagn Radiol 2009;38(1):44-52
2)Localization
Wolf F et al Radiology 2008;247:871-879.
Lee JM, et al. Eur Radiol 2003;13: 2540-7.
3) Maximum number of lesions/ lung
Multiple Lesions
Primary Cancer controlled. No extrapulmonary disease.
俯卧位,后位进针 | 复查(仰卧位) |
Literature Criteria |
N of studies (n=24) |
Literature Criteria |
N of studies (n=24) |
Pretreatment reccomendation |
|
Imaging criteria |
|
- Biopsy |
12 |
Limit value for lesion’s diameter |
11 |
- Coagulation disorders |
9 |
Extension of local disease |
19 |
- Specialist responsable of the choice |
12 |
Maximum Diameter |
11 |
Clinical criteria |
|
Localization (close to major vessels, heart, trachea, hilum) |
19 |
- Poor lung function |
19 |
Failure of conventional therapy |
17 |
- Comorbidity |
17 |
Surgery Refusal |
18 |
- Advanced age |
4 |
|
|
Patient selection conclusion